Finance

Lists
MPARK:IST
MLP Saglik Hizmetleri AS
TRY 426.75
+6.69%
(+26.75) 1D
Aug 7, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for MPARK...
Open
TRY 406.25
High
TRY 428.50
Low
TRY 406.25
Mkt. cap
81.51B
Avg. vol.
611.99K
Volume
2.06M
P/E ratio
14.07
52-wk high
TRY 514.00
52-wk low
TRY 304.00
EPS
TRY 30.33
Shares outstanding
191.01M
No. of employees
15K
Open
TRY 406.25
High
TRY 428.50
Low
TRY 406.25
Mkt. cap
81.51B
Avg. vol.
611.99K
Volume
2.06M
P/E ratio
14.07
52-wk high
TRY 514.00
52-wk low
TRY 304.00
EPS
TRY 30.33
Shares outstanding
191.01M
No. of employees
15K
Profile
Medical Park Hospitals Group, which has been active in the health care sector since 1995, offers service in various provinces of Turkey with more than 6,000 doctors and employees, 17 hospitals in total. Medical Park is the biggest hospital group in Turkey. The hospital chain was founded by Muharrem Usta, who currently chairs the company. The company owned two hospitals in Istanbul in 2005. In 2006, he initially sold 30% of the company shares to Sancak family. This partnership enabled a rapid growth of the company that led to the establishment of 13 hospitals with 2,000 beds within three years. By the end of 2009, 40% of the company shares were sold to the third biggest US-American global asset management firm The Carlyle Group. With this new partnership, the number of hospitals reached 17 with 2,771 beds in total that placed the company on first rank of its kind in Turkey. In March 2013, it was reported that the Carlyle Group sold its shares at Medical Park to the largest US-American private equity investment firm Texas Pacific Group. Wikipedia
About MLP Saglik Hizmetleri AS
CEOMuharrem Usta
Employees14.6K
Founded1993
Headquarters-
SectorHealth care provider
Previous reportsAll values in TRY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TRY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.06B
15.87B
16.25B
16.74B
Cost of goods sold
9.09B
11.33B
11.78B
12.59B
Cost of revenue
9.09B
11.33B
11.78B
12.59B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.06B
1.32B
1.40B
1.40B
Operating expense
1.39B
1.54B
1.92B
1.64B
Total operating expenses
10.48B
12.87B
13.70B
14.23B
Operating income
2.59B
3.00B
2.55B
2.51B
Other non operating income
235.22M
333.68M
763.32M
1.09B
EBT including unusual items
2.51B
3.24B
2.16B
1.96B
EBT excluding unusual items
2.52B
3.26B
2.22B
2.12B
Income tax expense
680.56M
1.56B
297.02M
408.00M
Effective tax rate
27.09%
48.19%
13.76%
20.84%
Other operating expenses
331.93M
213.73M
521.21M
233.00M
Net income
1.62B
1.46B
1.67B
1.37B
Net profit margin
12.39%
9.21%
10.26%
8.17%
Earnings per share
-
-
-
-
Interest and investment income
1.51B
1.68B
621.58M
11.00M
Interest expense
-1.69B
-1.75B
-1.70B
-1.32B
Net interest expenses
-177.17M
-67.71M
-1.08B
-1.31B
Depreciation and amortization charges
-
-
-
-
EBITDA
3.38B
3.94B
3.54B
3.50B
Gain or loss from assets sale
583.00K
-1.33B
-6.29M
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps